Long-term cost effectiveness of drotrecogin alfa (activated) : an unanswered question
Banks, S.M.; Gerstenberger, E.; Eichacker, P.Q.; Natanson, C.
Critical Care Medicine 31(1): 308-309
2003
ISSN/ISBN: 0090-3493 PMID: 12545035 Document Number: 559169
Document emailed within 1 workday
Related Documents
Maglio, D. 2002: Drotrecogin alfa (activated) for severe sepsis Connecticut Medicine 66(3): 145-150Macias, W.L.; Yan, S.B.; Grinnell, B.W. 2004: The development of drotrecogin alfa (activated) for the treatment of severe sepsis International Journal of Artificial Organs 27(5): 360-370
Albuali, W.H.; Singh, R.N.; Fraser, D.D.; Scott, L.A.; Kornecki, A. 2005: Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure Saudi Medical Journal 26(8): 1289-1292
Liang, J.; Streat, S.; Torrance, J.; Sleigh, J.; Freebairn, R.; Ramsay, M. 2003: Drotrecogin alfa (recombinant human activated protein C) in severe sepsis--a New Zealand viewpoint New Zealand Medical Journal 116(1181): U586
Lai, P.S.; Matteau, A.; Iddriss, A.; Hawes, J.C.L.; Ranieri, V.; Thompson, B.T. 2013: An updated meta-analysis to understand the variable efficacy of drotrecogin alfa (activated) in severe sepsis and septic shock Minerva Anestesiologica 79(1): 33-43
Wong, J. B.; Nevens, F. 2002: Cost-effectiveness of peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin as initial treatment of chronic hepatitis C in Belgium Acta Gastro-Enterologica Belgica 65(2): 110-111
Gøtzsche, P.C. 2013: There is no effect of drotrecogin alfa in severe sepsis Ugeskrift for Laeger 175(13): 903
Bartelink, A.K.M. 2006: Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis Nederlands Tijdschrift Voor Geneeskunde 150(7): 352-354
Rooijmans, H.G. 2001: Report of the Dutch Health Council on the cost-effectiveness of long-term psychotherapy Nederlands Tijdschrift Voor Geneeskunde 145(29): 1384-1386
Achterberg, W.P.; Gussekloo, J.; van den Hout, W.B. 2015: Cost-effectiveness research in elderly residents in long-term care: prevention is better than cure, but not always cheaper Nederlands tijdschrift voor geneeskunde 159: A8903
Smales, R.J.; Hawthorne, W.S. 1996: Long-term survival and cost-effectiveness of five dental restorative materials used in various classes of cavity preparations International Dental Journal 46(3): 126-130
Romero, M.; Huerfano, L.; Espinel, F. 2013: Cost-Effectiveness Analysis of using Levonorgestrel-Releasing Intrauterine System in Long-Term Contraception in Colombia Value in Health 16(3): A74-A75
Taylor, B.; Burns, D.; van de Wal, B.W.; MBewu, T.; Keeton, G.R. 2003: Should health care money in South Africa be spent on drotrecogin alfa? South African Medical Journal 93(7): 500-501
Morrison, C.S.; Nanda, K. 2012: Hormonal contraception and HIV: an unanswered question Lancet. Infectious Diseases 12(1): 2-3
Flöter, T.; Brunnmüller, U. 2002: Tilidine/naloxon retard in long-term administration in chronic pain and multimorbidity. Multicenter study of long-term tolerance and effectiveness in 2 years observation Fortschritte der Medizin. Originalien 120(1): 29-35
Thompson, H.C. 1983: The value of neonatal circumcision. An unanswered and perhaps unanswerable question American Journal of Diseases of Children 137(10): 939-940
Gilbert, M.S.; Capozzi, J. 1998: Unipolar or bipolar prosthesis for the displaced intracapsular hip fracture? An unanswered question Clinical Orthopaedics and Related Research 1998(353): 81-85
Duan, C.; Li, T.; Han, Z. 2001: Short-term and long-term effectiveness of endovascular embolization in treating intracranial aneurysms Zhonghua Yi Xue Za Zhi 81(10): 579-582
Hörmann, M. 1987: Brain contusion and "fetal" cyst in the arachnoid space. Question of correlation and long-term course Der Nervenarzt 58(9): 579-582
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14